SUN06 Updates in Contact Dermatitis
DESCRIPTION
The goal of this session is to provide updates on emerging topics in contact dermatitis both to educate colleagues, but also stimulate discussion about novel approaches for contact dermatitis. Topics to be discussed are how to manage contact dermatitis when the allergen cannot be avoided (e.g. diabetic devices), how to counsel patients on allergen avoidance in era in which a wealth of hair and skin care consumer products are available, and the utility of the Day 2 patch test read.
LEARNING OBJECTIVES
Select appropriate treatment/ management strategies for patients unable to avoid contact allergens (e.g. people with devices for diabetes management).
Counsel patients following patch testing regarding identification of allergens and recognition of potential product label inaccuracies.
Evaluate the utility of Day 2 patch test read.
SCHEDULE
12:30 PM
Managing Skin Reactions Associated with Diabetic Devices
Jennifer Chen, MD, FAAD
12:50 PM
Allergen Avoidance After Patch Testing: Counseling Patients in a New Era of Skincare
Jamie Schlarbaum, MD, FAAD
1:10 PM
Timing is Everything: Maximizing Accuracy in Patch Testing
Theodora K Karagounis, MD, FAAD
SPEAKERS
Jennifer Chen, MD, FAAD
Theodora K Karagounis, MD, FAAD
NYU Grossman School of Medicine
Jamie Schlarbaum, MD, FAAD
HANDOUTS
SPEAKER DISCLOSURES
Jennifer Chen, MD, FAAD
Almirall – Advisory Board(Fees); American Academy of Dermatology – Speaker/Faculty Education(Grants/Research Funding); American Contact Dermatitis Society – Board of Directors(No Compensation Received); Keylika – Consultant (1099 relationship)(Fees); Sanofi/Regeneron – Investigator(No Compensation Received);
Theodora K Karagounis, MD, FAAD
No financial relationships exist with ineligible companies.
Jamie Schlarbaum, MD, FAAD
No financial relationships exist with ineligible companies.